260 related articles for article (PubMed ID: 33125054)
1. The T cell CD6 receptor operates a multitask signalosome with opposite functions in T cell activation.
Mori D; Grégoire C; Voisinne G; Celis-Gutierrez J; Aussel R; Girard L; Camus M; Marcellin M; Argenty J; Burlet-Schiltz O; Fiore F; Gonzalez de Peredo A; Malissen M; Roncagalli R; Malissen B
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33125054
[TBL] [Abstract][Full Text] [Related]
2. CD6, a Rheostat-Type Signalosome That Tunes T Cell Activation.
Gonçalves CM; Henriques SN; Santos RF; Carmo AM
Front Immunol; 2018; 9():2994. PubMed ID: 30619347
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomics analysis of signalosome dynamics in primary T cells identifies the surface receptor CD6 as a Lat adaptor-independent TCR signaling hub.
Roncagalli R; Hauri S; Fiore F; Liang Y; Chen Z; Sansoni A; Kanduri K; Joly R; Malzac A; Lähdesmäki H; Lahesmaa R; Yamasaki S; Saito T; Malissen M; Aebersold R; Gstaiger M; Malissen B
Nat Immunol; 2014 Apr; 15(4):384-392. PubMed ID: 24584089
[TBL] [Abstract][Full Text] [Related]
4. CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76.
Hassan NJ; Simmonds SJ; Clarkson NG; Hanrahan S; Puklavec MJ; Bomb M; Barclay AN; Brown MH
Mol Cell Biol; 2006 Sep; 26(17):6727-38. PubMed ID: 16914752
[TBL] [Abstract][Full Text] [Related]
5. A sequence conserved between CD5 and CD6 binds an FERM domain and exerts a restraint on T-cell activation.
Breuning J; Brown MH
Immunology; 2019 Mar; 156(3):270-276. PubMed ID: 30460991
[TBL] [Abstract][Full Text] [Related]
6. CD6 attenuates early and late signaling events, setting thresholds for T-cell activation.
Oliveira MI; Gonçalves CM; Pinto M; Fabre S; Santos AM; Lee SF; Castro MA; Nunes RJ; Barbosa RR; Parnes JR; Yu C; Davis SJ; Moreira A; Bismuth G; Carmo AM
Eur J Immunol; 2012 Jan; 42(1):195-205. PubMed ID: 21956609
[TBL] [Abstract][Full Text] [Related]
7. Relevance of CD6-mediated interactions in T cell activation and proliferation.
Gimferrer I; Calvo M; Mittelbrunn M; Farnós M; Sarrias MR; Enrich C; Vives J; Sánchez-Madrid F; Lozano F
J Immunol; 2004 Aug; 173(4):2262-70. PubMed ID: 15294938
[TBL] [Abstract][Full Text] [Related]
8. Targeting CD6 for the treatment of experimental autoimmune uveitis.
Zhang L; Li Y; Qiu W; Bell BA; Dvorina N; Baldwin WM; Singer N; Kern T; Caspi RR; Fox DA; Lin F
J Autoimmun; 2018 Jun; 90():84-93. PubMed ID: 29472120
[TBL] [Abstract][Full Text] [Related]
9. The accessory molecules CD5 and CD6 associate on the membrane of lymphoid T cells.
Gimferrer I; Farnós M; Calvo M; Mittelbrunn M; Enrich C; Sánchez-Madrid F; Vives J; Lozano F
J Biol Chem; 2003 Mar; 278(10):8564-71. PubMed ID: 12473675
[TBL] [Abstract][Full Text] [Related]
10. CD6 as a therapeutic target in autoimmune diseases: successes and challenges.
Pinto M; Carmo AM
BioDrugs; 2013 Jun; 27(3):191-202. PubMed ID: 23568178
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents.
Velasco-de Andrés M; Casadó-Llombart S; Català C; Leyton-Pereira A; Lozano F; Aranda F
Cells; 2020 Dec; 9(12):. PubMed ID: 33287301
[TBL] [Abstract][Full Text] [Related]
12. T Cell Costimulation by CD6 Is Dependent on Bivalent Binding of a GADS/SLP-76 Complex.
Breuning J; Brown MH
Mol Cell Biol; 2017 Jun; 37(11):. PubMed ID: 28289074
[TBL] [Abstract][Full Text] [Related]
13. The ectodomains of the lymphocyte scavenger receptors CD5 and CD6 interact with tegumental antigens from Echinococcus granulosus sensu lato and protect mice against secondary cystic echinococcosis.
Mourglia-Ettlin G; Miles S; Velasco-De-Andrés M; Armiger-Borràs N; Cucher M; Dematteis S; Lozano F
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006891. PubMed ID: 30500820
[TBL] [Abstract][Full Text] [Related]
14. OX52 is the rat homologue of CD6: evidence for an effector function in the regulation of CD5 phosphorylation.
Castro MA; Nunes RJ; Oliveira MI; Tavares PA; Simões C; Parnes JR; Moreira A; Carmo AM
J Leukoc Biol; 2003 Jan; 73(1):183-90. PubMed ID: 12525577
[TBL] [Abstract][Full Text] [Related]
15. Addition of the C-terminus of CD6 to a chimeric antigen receptor enhances cytotoxicity and does not compromise expression.
Breuning J; Philip B; Brown MH
Immunology; 2019 Feb; 156(2):130-135. PubMed ID: 30300924
[TBL] [Abstract][Full Text] [Related]
16. PI3Kδ Forms Distinct Multiprotein Complexes at the TCR Signalosome in Naïve and Differentiated CD4
Luff DH; Wojdyla K; Oxley D; Chessa T; Hudson K; Hawkins PT; Stephens LR; Barry ST; Okkenhaug K
Front Immunol; 2021; 12():631271. PubMed ID: 33763075
[TBL] [Abstract][Full Text] [Related]
17. CD6: expression during development, apoptosis and selection of human and mouse thymocytes.
Singer NG; Fox DA; Haqqi TM; Beretta L; Endres JS; Prohaska S; Parnes JR; Bromberg J; Sramkoski RM
Int Immunol; 2002 Jun; 14(6):585-97. PubMed ID: 12039910
[TBL] [Abstract][Full Text] [Related]
18. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.
Hassan NJ; Barclay AN; Brown MH
Eur J Immunol; 2004 Apr; 34(4):930-40. PubMed ID: 15048703
[TBL] [Abstract][Full Text] [Related]
19. CD5 signalosome coordinates antagonist TCR signals to control the generation of Treg cells induced by foreign antigens.
Blaize G; Daniels-Treffandier H; Aloulou M; Rouquié N; Yang C; Marcellin M; Gador M; Benamar M; Ducatez M; Song KD; Burlet-Schiltz O; Saoudi A; Love PE; Fazilleau N; Gonzalez de Peredo A; Lesourne R
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12969-12979. PubMed ID: 32434911
[TBL] [Abstract][Full Text] [Related]
20. Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner.
Seggewiss R; Loré K; Greiner E; Magnusson MK; Price DA; Douek DC; Dunbar CE; Wiestner A
Blood; 2005 Mar; 105(6):2473-9. PubMed ID: 15572591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
